NCT00150995View on ClinicalTrials.gov

Tetrathiomolybdate in Hormone Refractory Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

May 31, 2001

Primary Completion Date

October 31, 2003

Study Completion Date

April 30, 2006

Conditions
Prostate Cancer
Interventions
DRUG

Tetrathiomolybdate

Trial Locations (1)

48109

The University of Michigan Comprehensive Cancer Center, Ann Arbor

All Listed Sponsors
lead

University of Michigan Rogel Cancer Center

OTHER

NCT00150995 - Tetrathiomolybdate in Hormone Refractory Prostate Cancer | Biotech Hunter | Biotech Hunter